Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ibuprofen
Reckitt Benckiser Healthcare (UK) Ltd
M01AE01
Ibuprofen
400mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 10010100; GTIN: 5012509973339 5012509973346 5012509974183 5012509980443
000000 000000 N/A 000000 FOR ADULTS AND CHILDREN & ADOLESCENTS BETWEEN 12 AND 18 YEARS: • Take one tablet with water up to three times a day as required. • To be taken preferably with food. • Leave at least 4 hours between doses. • Do not take more than three tablets in any 24 hour period. • Do not exceed the stated dose. CHILDREN UNDER 12 YEARS: • Not suitable for children under 12 years. IF YOU HAVE TAKEN MORE MEDICINE THAN YOU SHOULD, OR IF CHILDREN HAVE TAKEN THIS MEDICINE BY ACCIDENT, ALWAYS CONTACT A DOCTOR OR NEAREST HOSPITAL TO GET AN OPINION OF THE RISK AND ADVICE ON ACTION TO BE TAKEN. The symptoms can include nausea, stomach pain, vomiting (may be blood streaked), headache, ringing in the ears, confusion and shaky eye movement. At high doses, drowsiness, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), weakness and dizziness, blood in urine, cold body feeling, and breathing problems have been reported. POSSIBLE SIDE EFFECTS As with all medicines, these tablets can have side effects in some people. The elderly are more likely to suffer such effects. If you suffer from any of the following at any time during your treatment STOP TAKING the medicine and seek immediate medical help: • Passing blood in your faeces (stools/motions). • Passing black tarry stools. • Vomiting any blood or dark particles that look like coffee grounds. • Allergic reactions, which can include the following: bruising or facial swelling; swelling of the lips, throat and tongue causing difficulty swallowing or breathing; breathing problems, e.g. unexplained wheezing, shortness of breath, asthma or worsening of asthma; skin reactions, e.g. skin rashes, itching, urticaria (hives) which can be severe with blistering and peeling of the skin; rapid heart rate/palpitations, collapsing or low blood pressure. Seek medical help immediately. • Severe skin reaction known as DRESS syndrome. Symptoms of DRESS include: skin rash, fever, swelling of lymph nodes and an increase of eosinophils (a Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cuprofen Tablets 400 mg Ibuprofen Tablets BP 400 mg Cuprofen Maximum Strength Tablets Own label: UniChem Extra Strength Ibuprofen 400mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Ibuprofen 400 mg Excipients with known effect: Lactose See Section 6.1 for full list of excipients 3 PHARMACEUTICAL FORM Film-coated tablets (tablets) 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of rheumatic, muscular, dental and period pains and pain in backache, neuralgia, migraine and headache, and for the symptomatic relief of colds, flu and feverishness. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration and short-term use only. ADULTS, THE ELDERLY AND CHILDREN AND ADOLESCENTS BETWEEN 12 AND 18 YEARS: Undesirable effects may be minimised by using the effective dose for the shortest duration necessary to control symptoms (see section 4.4). If in children and adolescents this medicinal product is required for more than 3 days, or if symptoms worsen a doctor should be consulted. Adults should consult a doctor if symptoms persist or worsen, or if the product is required for more than 10 days. CHILDREN AND ADOLESCENTS BETWEEN 12 AND 18 YEARS: One tablet up to three times as day as required. ADULTS: One tablet up to three times as day as required. Leave at least four hours between doses and do not take more than 3 tablets in any 24 hour period. To be taken preferably after food. CHILDREN UNDER 12 YEARS: Not to be given to children under 12 years of age. 4.3 CONTRAINDICATIONS Hypersensitivity to ibuprofen or any of the excipients in the product. Patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to aspirin or other non steroidal anti- inflammatory drugs. Active or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding). History of gastrointestinal bleeding or perforation, relating to previous NSAIDs thera Read the complete document